Glasgow-based DeepMatter Group plc, the AIM-listed company focusing on digitizing chemistry, said on Thursday it has been selected as a partner for the University of Leeds following a £1.4 million EPSRC (Engineering and Physical Sciences Research Council) investment they received to develop automated precision manufacturing approaches in collaboration with the University of Sheffield, AstraZeneca, Somaserve and Samsung.
“DeepMatter will provide its DigitalGlassware platform, a cloud-based platform that allow chemists to share data in real-time and develop digitally enabled scale-up of advanced nanoparticle products,” said DeepMatter.
“Nanoparticles are an important component in ensuring safe and effective drug delivery of new-generation (mRNA) vaccines and certain anti-cancer drugs.
“The technology to digitally enable the scale-up of advanced nanoparticle products will be a sustainable, cost-effective alternative to the current method of production, and brings innovation beyond a laboratory setting across several manufacturing environments.
“DigitalGlassware was selected due to its strong fit for early-stage chemical development.
“It comprises a cloud-based software platform, which allows scientists to easily bring together digitised synthesis protocols (recipes) and contextualises time-course sensor streams from a range of analytical instrumentation, importantly in real-time.
“In addition to the cloud-based software, DeepMatter will provide its proprietary low-footprint sensor package, DeviceX, which provides a new perspective on chemical reaction data, as well as a hardware device to interface with the continuous platforms at the University of Leeds.
“Because of the structuring of content enabled by DigitalGlassware in the cloud, the aggregated chemical data is easily amenable to ML and AI applications, from which derived insights can be applied to shape new experimental design to improve the outcome of the Grant.”
Dr Nicholas Warren from the School of Chemical and Process Engineering at the University of Leeds is leading the research alongside colleagues Dr Richard Bourne and Dr Thomas Chamberlain from the School of Chemistry, and researchers from the University of Sheffield.